X

New Study Outlines New Ways to Treat Anthrax Infection

by Thilaka Ravi on  May 20, 2010 at 9:16 AM Research News   - G J E 4
A -A +
 New Study Outlines New Ways to Treat Anthrax Infection
According to a new study, anthrax-causing bacteria can be engineered to shed their invisibility cloaks, making it easier for the immune system to eradicate it.

The study has been published in Microbiology.

The work could lead to new measures to treat anthrax infection in the event of a biological warfare attack.

Bacillus anthracis is a particularly lethal pathogen because it manages to escape recognition by the host's immune system by coating itself with a protective capsule around its surface. A key bacterial enzyme called capsule depolymerase (CapD) anchors the capsule to the cell surface. CapD can also cut and release some of the capsule into small fragments that are thought to interfere with specific parts of the immune system, offering further protection to the bacterium.

Scientists at the U.S. Army Medical Research Institute of Infectious Diseases discovered that by engineering B. anthracis to produce higher-than-normal amounts of CapD, the protective capsule is chopped up and released as tiny fragments. The bacterium is left nearly completely unmasked and therefore vulnerable to immediate detection and destruction by the macrophage and neutrophil cells of the immune system.

"By engineering B. anthracis to over-produce CapD, we are effectively turning the bacterium's own weapon on itself," explained Dr. Arthur Friedlander, one of the principal investigators in the study.

B. anthracis is the most commonly mentioned pathogen associated with biological warfare. This bacterium can form resilient spores that survive dormant in the environment for long periods of time. When these spores are aerosolised the bacterium can be very effectively distributed. After human inhalation the spores reactivate and cause severe infection that is usually fatal if left untreated.

Dr Friedlander believes his groups' findings could have significant clinical impact.

"Many pathogenic bacteria, including B. anthracis, produce a capsule surrounding them that prevents the infected host from killing them, improving their chances of causing disease," he xplained. "Understanding the mechanisms of virulence used by the anthrax bacterium is vital to developing medical countermeasures against it in the event of a biological attack."

More News on:

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

Most Popular News on Medindia

P
M
View All >>
X

Ask an Expert

Ask an Expert+
s
Infants at Measles' Risk in First Year: Research
 Infants at Measles' Risk in First Year: Research
S  Gene Therapy Could Help Treat Pulmonary Arterial Hypertension
Gene Therapy Could Help Treat Pulmonary Arterial ...